Details about Don Husereau

Access statistics for papers by Don Husereau.

Last updated 2024-03-17. Update your information in the RePEc Author Service.

Short-id: phu379

Journal Articles

2024

1. Comment on: “Adding Value to CHEERS: New Reporting Standards for Value of Information Analyses”
   Applied Health Economics and Health Policy, 2024, 22, (2), 265-267
2. Reporting Economic Evaluations with Value of Information Analyses Using the CHEERS Value of Information (CHEERS-VOI) Reporting Guideline
   Medical Decision Making, 2024, 44, (2), 127-128

2022

3. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
   Applied Health Economics and Health Policy, 2022, 20, (2), 213-221 View citations (5)
   Also in The European Journal of Health Economics, 2022, 23, (8), 1309-1317 (2022) View citations (6)
   PharmacoEconomics, 2022, 40, (6), 601-609 (2022) View citations (7)
4. Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
   Applied Health Economics and Health Policy, 2022, 20, (5), 781-782 View citations (3)

2021

5. Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists
   The European Journal of Health Economics, 2021, 22, (5), 723-733
6. Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT)
   PharmacoEconomics, 2021, 39, (9), 1075-1084

2020

7. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis
   PLOS ONE, 2020, 15, (10), 1-35
8. Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists
   Applied Health Economics and Health Policy, 2020, 18, (3), 375-392

2019

9. Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB)
   Medical Decision Making, 2019, 39, (4), 371-379

2018

10. Economic evaluations of eHealth technologies: A systematic review
    PLOS ONE, 2018, 13, (6), 1-11 View citations (4)
11. Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment
    PharmacoEconomics, 2018, 36, (1), 7-15 View citations (1)
12. Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching
    Applied Health Economics and Health Policy, 2018, 16, (3), 279-288

2016

13. Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation
    Applied Health Economics and Health Policy, 2016, 14, (3), 313-322

2015

14. How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States?
    Applied Health Economics and Health Policy, 2015, 13, (3), 273-279 View citations (1)
15. Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration
    PharmacoEconomics, 2015, 33, (5), 535-536

2014

16. A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development
    PLOS ONE, 2014, 9, (3), 1-10 View citations (11)

2013

17. Capturing Value from Health Technologies in Lean Times
    C.D. Howe Institute Commentary, 2013, (396) View citations (2)
18. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement
    PharmacoEconomics, 2013, 31, (5), 361-367 View citations (246)
    Also in The European Journal of Health Economics, 2013, 14, (3), 367-372 (2013) View citations (217)